← Open Payments lookup

LAURI HALLER: Open Payments

NPI 1811404957 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,672 in 80 payments from 14 companies in 2025. Trend: 2023 $1,231 · 2024 $1,136 · 2025 $1,672

Food & beverage: $1,672
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$257
Alkermes, Inc.11$226
Neurocrine BioSciences, Inc.13$185
Supernus Pharmaceuticals, Inc.11$182
ABBVIE INC.8$171
Axsome Therapeutics, Inc.8$148
Otsuka America Pharmaceutical, Inc.5$97
Indivior Inc.4$89
Braeburn Inc.3$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60

Products named: COBENFY, ARISTADA, INGREZZA, Qelbree, VRAYLAR, REXULTI, Auvelity, SUBLOCADE.

Industry payments across LA — which companies pay providers there.